Seres Therapeutics Inc banner

Intrinsic Value

Not Available for MCRB

There is not enough data to reliably calculate the intrinsic value for Seres Therapeutics Inc.

Do our valuations actually work? See backtest results .

Alternatives to MCRB

Fundamental Analysis

What Seres Therapeutics Does

Biotechnology Health Care

Seres Therapeutics is a biotechnology company that develops therapies based on the human microbiome, the community of bacteria that live in the body. Its main products are designed to restore a healthier balance of gut microbes, especially for patients whose intestinal bacteria have been disrupted by illness or antibiotic use. The company’s best-known work has focused on treating recurrent Clostridioides difficile infection, a serious gut infection that often comes back after standard antibiotics.

Headquarters
United States of America US
Employees
66
IPO date
Jun 26, 2015
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Ownership

Seres Therapeutics insiders are selling less than usual

Insider trading · Last trade on Aug 17, 2026

Sold $10k 5 insiders
Bought $0 Nobody bought
Trades by date
Open insider trading

Continue MCRB Research

Decided on Seres Therapeutics? Get an email when MCRB reaches the price you’d buy at. Free with an account.

Other Seres Therapeutics listings

Back to Top